Zkusit zdarma
Janux Therapeutics, Inc.

Janux Therapeutics, Inc.

JANX
Cena:
$ 14.52
+0.11 (0.76%)
Valuace
100
Růst
30
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates

20:11 07-05-2026

Janux Therapeutics, Inc. (JANX) came out with a quarterly loss of $0.39 per share versus the Zacks C...

How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%

How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%

10:55 07-05-2026

The consensus price target hints at an 180.4% upside potential for Janux Therapeutics (JANX). While ...

Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value

Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value

19:33 04-05-2026

Janux Therapeutics, Inc. is upgraded to Strong Buy, trading below cash value with a robust cash runw...

Janux Therapeutics Announces Discontinuation of JANX008 Clinical Development

Janux Therapeutics Announces Discontinuation of JANX008 Clinical Development

16:01 27-04-2026

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (“Janux”), a clinical-stage ...

Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014

Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014

16:01 16-04-2026

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopha...

Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment

Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment

8:01 01-04-2026

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopha...

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Recommendation of “Moderate Buy” from Analysts

2:23 23-03-2026

Shares of Janux Therapeutics, Inc. (NASDAQ: JANX - Get Free Report) have been assigned an average ra...

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011

7:00 17-02-2026

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JAN...

Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?

Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?

10:55 03-02-2026

The average of price targets set by Wall Street analysts indicates a potential upside of 319.2% in J...

Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer

Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer

7:00 26-01-2026

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company dev...

JANX Enters Global Oncology Collaboration With BMY, Stock Rises

JANX Enters Global Oncology Collaboration With BMY, Stock Rises

8:20 23-01-2026

Janux Therapeutics struck a global licensing deal for its tumor-activated platforms, sending shares ...

Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million

Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million

14:02 22-01-2026

Janux Therapeutics, Inc. (NASDAQ: JANX) on Thursday announced a collaboration and exclusive worldwid...

Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors

Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors

7:00 22-01-2026

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (“Janux”), a clinical-stage ...

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Rating of “Moderate Buy” from Brokerages

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Rating of “Moderate Buy” from Brokerages

3:32 07-01-2026

Janux Therapeutics, Inc. (NASDAQ: JANX - Get Free Report) has earned a consensus rating of "Moderate...

Janux Therapeutics (NASDAQ:JANX) Sets New 52-Week Low – Time to Sell?

Janux Therapeutics (NASDAQ:JANX) Sets New 52-Week Low – Time to Sell?

2:14 02-01-2026

Janux Therapeutics, Inc. (NASDAQ: JANX - Get Free Report)'s stock price hit a new 52-week low during...

Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study

Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study

16:05 23-12-2025

SAN DIEGO--(BUSINESS WIRE)--Janux provided a program update on its Phase 1 study of JANX008, an EGFR...

32,772 Shares in Janux Therapeutics, Inc. $JANX Purchased by Capital Fund Management S.A.

32,772 Shares in Janux Therapeutics, Inc. $JANX Purchased by Capital Fund Management S.A.

3:58 06-12-2025

Capital Fund Management S.A. purchased a new stake in Janux Therapeutics, Inc. (NASDAQ: JANX) in the...

Options Exercise: Janux Executive Sells 16,665 Shares for $501,000

Options Exercise: Janux Executive Sells 16,665 Shares for $501,000

10:20 04-12-2025

Meyer Andrew Hollman, Chief Business Officer at Janux Therapeutics (JANX 1.70%), exercised 16,665 op...

Janux Therapeutics Stock Hits 52-Week Low After Trial Update

Janux Therapeutics Stock Hits 52-Week Low After Trial Update

10:58 02-12-2025

Janux Therapeutics Inc. (NASDAQ: JANX) stock hit a 52-week low on Tuesday after the company released...

Janux dives as gaps in prostate cancer study data worry investors

Janux dives as gaps in prostate cancer study data worry investors

10:50 02-12-2025

Shares of Janux Therapeutics slumped nearly 50% on Tuesday as investors reacted to limited disclosur...

close

JANUX THERAPEUTICS APPOINTS WILLIAM GO, M.D., PH.D., AS CHIEF MEDICAL OFFICER

26-01-2026
SAN DIEGO--(BUSINESS WIRE)--JANUX THERAPEUTICS, INC., A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY DEV...
Více zde

JANUX THERAPEUTICS ANNOUNCES COLLABORATION AND EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH BRISTOL MYERS SQUIBB TO DEVELOP A NOVEL TUMOR-ACTIVATED THERAPEUTIC FOR SOLID TUMORS

22-01-2026
SAN DIEGO--(BUSINESS WIRE)--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (“JANUX”), A CLINICAL-STAGE ...
Více zde

JANUX THERAPEUTICS PROVIDES PROGRAM UPDATE ON ONGOING PHASE 1 JANX008 STUDY

23-12-2025
SAN DIEGO--(BUSINESS WIRE)--JANUX PROVIDED A PROGRAM UPDATE ON ITS PHASE 1 STUDY OF JANX008, AN EGFR...
Více zde

JANUX ANNOUNCES ENCOURAGING EFFICACY AND SAFETY PROFILE FROM ONGOING PHASE 1 CLINICAL TRIAL FOR JANX007 IN MCRPC

01-12-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX ANNOUNCES ENCOURAGING EFFICACY AND SAFETY PROFILE FROM O...
Více zde

JANUX THERAPEUTICS TO HOST VIRTUAL EVENT DISCUSSING UPDATED PHASE 1A AND PHASE 1B CLINICAL DATA FOR JANX007 IN MCRPC

24-11-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (JANUX), A CLINICAL-ST...
Více zde

JANUX THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

06-11-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (JANUX), A CLINICAL-ST...
Více zde

JANUX THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

07-08-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (JANUX), A CLINICAL-ST...
Více zde

JANUX THERAPEUTICS ANNOUNCES CLINICAL MILESTONE ACHIEVEMENT IN TRACTR COLLABORATION WITH MERCK

05-08-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (JANUX), A CLINICAL-ST...
Více zde

JANUX THERAPEUTICS HIGHLIGHTS PIPELINE PROGRESS AND BEST-IN-CLASS POTENTIAL OF NOVEL BISPECIFIC PLATFORM FOR AUTOIMMUNE DISEASES AT VIRTUAL R&D DAY

24-07-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (JANUX), A CLINICAL-ST...
Více zde

JANUX THERAPEUTICS TO HOST VIRTUAL R&D DAY ON JULY 24, 2025

17-07-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS TO HOST VIRTUAL R&D DAY ON JULY 24, 2025....
Více zde

JANUX THERAPEUTICS APPOINTS JANEEN DOYLE AS CHIEF CORPORATE AND BUSINESS DEVELOPMENT OFFICER

15-05-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (JANUX), A CLINICAL-ST...
Více zde

JANUX THERAPEUTICS INITIATES PHASE 1B EXPANSION STUDIES WITH JANX007 IN PATIENTS WITH PROSTATE CANCER AND PROVIDES PROGRAM UPDATES

05-05-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS INITIATES PHASE 1B EXPANSION STUDIES WITH J...
Více zde

JANUX THERAPEUTICS PROMOTES ZACHARIAH MCIVER, D.O., PH.D. TO CHIEF MEDICAL OFFICER

24-01-2025
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS PROMOTES ZACHARIAH MCIVER, D.O., PH.D. TO C...
Více zde

JANUX THERAPEUTICS ANNOUNCES CLOSING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS INCLUDING FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES FOR TOTAL GROSS PROCEEDS OF $402.5 MILLION

06-12-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (JANUX), A CLINICAL-ST...
Více zde

JANUX THERAPEUTICS ANNOUNCES PRICING OF $350.0 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

04-12-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (JANUX), A CLINICAL-ST...
Více zde

JANUX THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING

03-12-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING....
Více zde

JANUX ANNOUNCES DOSES SELECTED FOR PHASE 1B EXPANSION TRIALS SUPPORTED BY ENCOURAGING EFFICACY AND SAFETY PROFILE OBSERVED IN PHASE 1A DOSE ESCALATION FOR JANX007 IN MCRPC

02-12-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX ANNOUNCES EFFICACY AND SAFETY PROFILE OBSERVED IN PHASE ...
Více zde

JANUX THERAPEUTICS TO HOST VIRTUAL EVENT DISCUSSING UPDATED CLINICAL DATA IN PHASE 1A DOSE ESCALATION FOR JANX007 IN MCRPC AND DOSES SELECTED FOR PHASE 1B EXPANSION STUDIES

25-11-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS TO HOST VIRTUAL EVENT....
Více zde

JANUX THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

06-11-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--3Q24 EARNINGS RELEASE....
Více zde

JANUX THERAPEUTICS ANNOUNCES UPDATES TO BOARD OF DIRECTORS

22-07-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS, INC. (NASDAQ: JANX) (JANUX), A CLINICAL-ST...
Více zde

JANUX THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

07-05-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULT...
Více zde

JANUX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

08-03-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 F...
Více zde

JANUX THERAPEUTICS ANNOUNCES PRICING OF $296.5 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

29-02-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS ANNOUNCES PRICING OF $296.5 MILLION UNDERWR...
Více zde

JANUX THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

27-02-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMO...
Více zde

JANUX ANNOUNCES ENCOURAGING SAFETY AND EFFICACY DATA IN ONGOING DOSE ESCALATION TRIALS FOR PSMAXCD3-TRACTR JANX007 IN MCRPC AND EGFRXCD3-TRACTR JANX008 IN SOLID TUMORS

26-02-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--PSMAXCD3-TRACTR JANX007 IN MCRPC AND EGFRXCD3-TRACTR JANX008 I...
Více zde

JANUX THERAPEUTICS TO HOST VIRTUAL EVENT DISCUSSING UPDATED CLINICAL DATA FOR PSMA-TRACTR JANX007 AND EGFR-TRACTR JANX008

20-02-2024
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS TO HOST VIRTUAL EVENT DISCUSSING UPDATED CL...
Více zde

JANUX THERAPEUTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

07-11-2023
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULT...
Více zde

JANUX THERAPEUTICS ANNOUNCES PRICING OF $60 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

17-07-2023
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS ANNOUNCES PRICING OF $60 MILLION UNDERWRITT...
Více zde

JANUX THERAPEUTICS APPOINTS ZACHARIAH MCIVER, D.O., PH.D., VICE PRESIDENT, CLINICAL DEVELOPMENT

05-06-2023
SAN DIEGO--(BUSINESS WIRE)---- $JANX #CD28--JANUX THERAPEUTICS APPOINTS ZACHARIAH MCIVER, D.O., PH.D...
Více zde

JANUX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

10-03-2023
SAN DIEGO--(BUSINESS WIRE)---- $JANX--JANUX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 F...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-22 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-09-19 01:00:008-KStáhnout
2025-09-19 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-13 01:00:008-KStáhnout
2025-06-13 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2024-12-05 00:00:008-KStáhnout
2024-12-04 23:00:008-KStáhnout
2024-12-02 00:00:008-KStáhnout
2024-12-01 23:00:008-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-07-22 01:00:008-KStáhnout
2024-07-22 00:00:008-KStáhnout
2024-06-28 01:00:008-KStáhnout
2024-06-28 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-03-08 00:00:008-KStáhnout
2024-03-08 00:00:0010-KStáhnout
2024-03-07 23:00:008-KStáhnout
2024-03-07 23:00:0010-KStáhnout
2024-02-29 00:00:008-KStáhnout
2024-02-28 23:00:008-KStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-27 23:00:008-KStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 00:00:008-KStáhnout
2024-02-25 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-07-18 01:00:008-KStáhnout
2023-07-18 00:00:008-KStáhnout
2023-07-17 01:00:008-KStáhnout
2023-07-17 00:00:008-KStáhnout
2023-06-23 01:00:008-KStáhnout
2023-06-23 00:00:008-KStáhnout
2023-06-20 01:00:008-KStáhnout
2023-06-20 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-03-31 01:00:008-KStáhnout
2023-03-31 00:00:008-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-10 00:00:0010-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-03-09 23:00:0010-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-09-22 01:00:008-KStáhnout
2022-09-22 00:00:008-KStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-06-15 01:00:008-KStáhnout
2022-06-15 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-05-02 01:00:008-KStáhnout
2022-05-02 00:00:008-KStáhnout
2022-03-18 00:00:008-KStáhnout
2022-03-18 00:00:0010-KStáhnout
2022-03-17 23:00:008-KStáhnout
2022-03-17 23:00:0010-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-10-01 01:00:008-KStáhnout
2021-10-01 00:00:008-KStáhnout
2021-09-09 01:00:008-KStáhnout
2021-09-09 00:00:008-KStáhnout
2021-08-27 01:00:008-KStáhnout
2021-08-27 00:00:008-KStáhnout
2021-08-10 01:00:008-KStáhnout
2021-08-10 01:00:0010-QStáhnout
2021-08-10 00:00:008-KStáhnout
2021-08-10 00:00:0010-QStáhnout
2021-07-16 01:00:008-KStáhnout
2021-07-16 00:00:008-KStáhnout
2021-06-15 01:00:008-KStáhnout
2021-06-15 00:00:008-KStáhnout
preloader